
Loading...
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond

Loading...
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond
About Ceribell
Ceribell produces the world’s first brain monitor for point-of-care seizure triage and treatment. Our groundbreaking technology enables healthcare providers to test for a suspected seizure and then deliver treatments within minutes.
We are a rapidly growing venture capital-backed medical technology startup. Ceribell is being used in hundreds of community hospitals, large academic facilities and major IDN’s across the country. With extensive clinical validation of the effectiveness of our product and significant growth potential, Ceribell is a fantastic career opportunity.
Position Description:
Ceribell is seeking a dynamic and results-driven Senior Manager for the Go-To-Market (GTM) team. This role is responsible for developing, executing, and refining the launch strategy for new features, product extensions, and additional indications to ensure successful adoption from the commercial team and, ultimately, customers. The ideal candidate should demonstrate strong strategic and analytical skills and be effective working across functions as the launch owner. You will collaborate closely with Product, Marketing, and Sales teams to ensure alignment and ...
The Real Dill ☘️
AI seems to be all the rage, but Ceribell is using AI alongside it's proprietary hardware to accelerate diagnosing seizures in acute care settings. Three terms jump out in some of their news releases: "proprietary, portable, and rapidly deployable" - meaning their lightweight device plus powerful AI algorithm could provide an edge over traditional EEG seizure-detection systems. By all accounts, this seems to be coming to fruition - their July 2024 publication boasted 4 days shorter median ICU length of stay, and a 19 hour faster median time to EEG acquisition - both hugely important in the acute care setting. (July 2024)
Jon Lee, PT, DPT, OCS, FAAOMPT, MBA
Pickle co-founder
Point-of-Care EEG solutions for monitoring seizures
MissionTo make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions.
Wow FactorAchieved FDA Breakthrough Device designations in 2022 and 2023
Pickle is not affiliated with listed companies unless otherwise noted.